Internal Medicine, Hematology & Oncology · Ocoee, FL
NPI
1790936409
Since 2008
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
9900 W Colonial Dr
Ocoee, FL, 34761
Phone (321) 843-7440
Groups this clinician bills Medicare through
Medicare paid, 2024
$69K
737 services
Medicare patients, 2024
324
Average age 74
Drug cost, 2024
$3.4M
1,745 prescriptions
Company payments, 2025
$55.06
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Regan D Rostorfer was code 99215 (office e&m - established), 408 times for 190 patients. In total Regan D Rostorfer billed 737 services in 7 codes, and Medicare paid $69K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-04-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 408 | 190 | $99.53 | $41K |
| 99214 Office E&M - Established | Facility | 137 | 105 | $57.77 | $7,915 |
| 99233 Hospital E&M - Subsequent | Facility | 56 | 21 | $92.04 | $5,154 |
| 99205 Office E&M - New | Facility | 41 | 41 | $132.82 | $5,446 |
| 99223 Hospital E&M - Initial | Facility | 37 | 35 | $130.13 | $4,815 |
| 99497 Care Management/Coordination | Facility | 28 | 22 | $57.95 | $1,623 |
| 99215 Office E&M - Established | Office | 25 | 19 | $133.44 | $3,336 |
By year: 2022 $94K for 1,086 services; 2023 $86K for 942 services; 2024 $69K for 737 services.
Medicare prescription drug claims, 2024
In 2024, the drug Regan D Rostorfer prescribed most often to Medicare patients was Anastrozole, with 780 prescriptions and refills. In total Regan D Rostorfer wrote 1,745 Medicare prescriptions that cost $3.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 780 | 2,202 | 228 | $15K |
| Letrozole Generic | 220 | 622 | 61 | $5,592 |
| Verzenio Abemaciclib | 117 | 117 | 17 | $1.8M |
| Ibrance Palbociclib | 90 | 90 | 12 | $1.3M |
| Tamoxifen Citrate Generic | 79 | 235 | 27 | $2,912 |
| Raloxifene Hcl Generic | 67 | 183 | 21 | $2,851 |
| Prochlorperazine Maleate Generic | 56 | 56 | 31 | $620 |
| Exemestane Generic | 54 | 146 | 18 | $12K |
| Ondansetron Hcl Generic | 44 | 48 | 22 | $480 |
| Lidocaine-Prilocaine Lidocaine/Prilocaine | 21 | 21 | 16 | $243 |
| Gabapentin Generic | 20 | 38 | Under 11 | $163 |
| Eliquis Apixaban | 19 | 43 | Under 11 | $24K |
| Dexamethasone Generic | 16 | 17 | Under 11 | $464 |
| Everolimus Generic | 12 | 12 | Under 11 | $11K |
| Pantoprazole Sodium Generic | 12 | 14 | Under 11 | $45.06 |
Brand drugs: 253 claims; generic drugs: 1,492 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Regan D Rostorfer $55.06 ($55.06 in general payments such as food, travel and fees) from 2 companies. The largest payer was Stryker Corporation with $30.59.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.